Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2536.45 and 2601.45
| Intraday Target 1 | 2522.63 |
| Intraday Target 2 | 2550.27 |
| Intraday Target 3 | 2587.6333333333 |
| Intraday Target 4 | 2615.27 |
| Intraday Target 5 | 2652.63 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 19 February 2026 | 2577.90 (-0.23%) | 2584.00 | 2560.00 - 2625.00 | 0.5824 times | Wed 18 February 2026 | 2583.80 (-0.76%) | 2603.60 | 2578.60 - 2644.00 | 0.4566 times | Tue 17 February 2026 | 2603.60 (0.24%) | 2590.80 | 2579.00 - 2627.00 | 0.8956 times | Mon 16 February 2026 | 2597.30 (0.11%) | 2590.00 | 2584.80 - 2639.00 | 0.3476 times | Fri 13 February 2026 | 2594.40 (-2.78%) | 2645.00 | 2584.80 - 2668.50 | 0.6231 times | Thu 12 February 2026 | 2668.50 (-1.14%) | 2705.70 | 2644.80 - 2705.70 | 0.4434 times | Wed 11 February 2026 | 2699.30 (2.91%) | 2622.00 | 2610.00 - 2719.80 | 1.1736 times | Tue 10 February 2026 | 2622.90 (4.24%) | 2550.40 | 2541.60 - 2675.00 | 3.6394 times | Mon 09 February 2026 | 2516.20 (1.3%) | 2489.00 | 2475.00 - 2540.00 | 1.0706 times | Fri 06 February 2026 | 2484.00 (1.61%) | 2444.60 | 2405.00 - 2489.00 | 0.7677 times | Thu 05 February 2026 | 2444.60 (1.56%) | 2407.10 | 2370.30 - 2456.50 | 0.5224 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2526.95 and 2610.95
| Weekly Target 1 | 2509.97 |
| Weekly Target 2 | 2543.93 |
| Weekly Target 3 | 2593.9666666667 |
| Weekly Target 4 | 2627.93 |
| Weekly Target 5 | 2677.97 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 19 February 2026 | 2577.90 (-0.64%) | 2590.00 | 2560.00 - 2644.00 | 0.5872 times | Fri 13 February 2026 | 2594.40 (4.44%) | 2489.00 | 2475.00 - 2719.80 | 1.7884 times | Fri 06 February 2026 | 2484.00 (3.43%) | 2421.40 | 2342.10 - 2489.00 | 0.9145 times | Fri 30 January 2026 | 2401.60 (3.81%) | 2319.00 | 2278.30 - 2442.90 | 0.8108 times | Fri 23 January 2026 | 2313.40 (-1.36%) | 2345.90 | 2220.30 - 2420.00 | 1.0494 times | Fri 16 January 2026 | 2345.40 (-1.13%) | 2372.00 | 2337.60 - 2417.10 | 0.574 times | Fri 09 January 2026 | 2372.10 (-4.5%) | 2484.90 | 2350.00 - 2528.00 | 0.9743 times | Fri 02 January 2026 | 2483.80 (0.79%) | 2483.00 | 2362.60 - 2487.70 | 1.9726 times | Fri 26 December 2025 | 2464.30 (-2.56%) | 2530.10 | 2459.50 - 2550.10 | 0.4685 times | Fri 19 December 2025 | 2529.00 (-2.76%) | 2587.70 | 2506.70 - 2608.90 | 0.8602 times | Fri 12 December 2025 | 2600.80 (2.17%) | 2545.60 | 2491.00 - 2635.00 | 1.3463 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2460 and 2837.7
| Monthly Target 1 | 2168.9 |
| Monthly Target 2 | 2373.4 |
| Monthly Target 3 | 2546.6 |
| Monthly Target 4 | 2751.1 |
| Monthly Target 5 | 2924.3 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 19 February 2026 | 2577.90 (7.34%) | 2421.40 | 2342.10 - 2719.80 | 0.5389 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.5877 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 0.9604 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 0.8011 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.5202 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 0.8286 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.1467 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 0.7001 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 1.4008 times | Fri 30 May 2025 | 3298.60 (11.27%) | 2935.30 | 2693.90 - 3398.00 | 2.5155 times | Wed 30 April 2025 | 2964.60 (2.92%) | 2872.00 | 2401.00 - 3148.00 | 1.8806 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2399.1 and 2898.6
| Yearly Target 1 | 2006.5 |
| Yearly Target 2 | 2292.2 |
| Yearly Target 3 | 2506 |
| Yearly Target 4 | 2791.7 |
| Yearly Target 5 | 3005.5 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Thu 19 February 2026 | 2577.90 (4.22%) | 2476.00 | 2220.30 - 2719.80 | 0.1483 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6731 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2726 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2633 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7338 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9788 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0923 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4672 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2376 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1329 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1332 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. But this trend seems to be weakening.
Price is above an important level of 2560.73 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.
Munafa value: 65 as on Thu 19 February 2026
This Munafa value indicates that the stock is moving sideways and there is no definite momentum in the stock.
SMA20 is at 2496 and price is deviating by 112 points
Upper Bollinger band is at 2720 and lower is at 2272, while middle bands are at 2384 and 2608
Price is coming down
Price is above 20day SMA
Price is in lower range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for GlaxosmithklinePharmaceuticals in short term and the buy signal is strong.
GlaxosmithklinePharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for GlaxosmithklinePharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2603 and GlaxosmithklinePharmaceuticals GLAXO stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2591.4 |
| 12 day DMA | 2566.63 |
| 20 day DMA | 2495.36 |
| 35 day DMA | 2450.98 |
| 50 day DMA | 2474.8 |
| 100 day DMA | 2546.5 |
| 150 day DMA | 2651.98 |
| 200 day DMA | 2782.88 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2590.07 | 2596.16 | 2602.34 |
| 12 day EMA | 2560.73 | 2557.61 | 2552.85 |
| 20 day EMA | 2526.54 | 2521.14 | 2514.55 |
| 35 day EMA | 2508.76 | 2504.69 | 2500.03 |
| 50 day EMA | 2491.31 | 2487.78 | 2483.86 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2591.4 | 2609.52 | 2632.62 |
| 12 day SMA | 2566.63 | 2554.75 | 2540.03 |
| 20 day SMA | 2495.36 | 2485.47 | 2470.21 |
| 35 day SMA | 2450.98 | 2448 | 2442.29 |
| 50 day SMA | 2474.8 | 2474.42 | 2473.63 |
| 100 day SMA | 2546.5 | 2548.1 | 2549.73 |
| 150 day SMA | 2651.98 | 2656.12 | 2660.15 |
| 200 day SMA | 2782.88 | 2784.2 | 2785.75 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 56.39 and PE is: 45.72
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
EPS is 56.09 and PE is: 45.96
Last quarter profit: (June 2025 quarter) 205.01 crores (12.44%)
Debt: 9.95 in crores
Market capitalization: 47197.61
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
